How do HMO modulate the immune system in infants with CMPA? emerging evidence  and clinical implications.

How do HMO modulate the immune system in infants with CMPA? emerging evidence  and clinical implications.

Introduction

Clinical implications of 2’FL and LNnT in the nutritional management of CMPA

Mechanisms of HMO in modulating immune response

Evolving our understanding of the impact of 2’FL and LNnT on the gut microbiome and metabolome in infants with CMPA

Q + A

From the same author